As cannabis producers struggle to create meaningful relationships between brands and consumers, accessories may offer a solution, according to one executive.


Following a panel at the Lift & Co. (TSXV:LIFT) Cannabis Business Conference (LCBC) in Vancouver, the Investing News Network talked with Nick Kuzyk, chief strategy officer and senior vice president of capital markets for High Tide (CSE:HITI), about the power accessories will have in creating brand awareness for massive licensed producers (LPs).

“The accessory space has always been legal, but now it’s being embraced as an opportunity for branding and marketing purposes,” Kuzyk said.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

High Tide, a retail-focused cannabis company with stores in Alberta, also has a division working on the development of cannabis accessories. In December 2018, High Tide obtained a C$10-million investment from Canadian firm Aurora Cannabis (NYSE:ACB,TSX:ACB).

Kuzyk said Aurora first approached High Tide with specific ideas on items; after the company completed those, more LPs with similar pursuits have been in contact. He added that thanks to the “increasing of the spotlight on the cannabis industry,” there is larger demand for the accessories and tools needed to consume these new products.

In Canada, heavy restrictions on promotion and branding from Health Canada have created roadblocks for LPs looking to popularize product brands following the legalization of cannabis on October 17.

Nick Pateras, vice president of strategy at Lift, told LCBC attendees that data from Lift indicates that consumers are not getting attached to brands from official producers as much as strains.

Pateras said that a recent survey shows 64 percent of consumers named a strain rather than a brand or company when asked about legal products.

Commenting on the Aurora investment, Raj Grover, president and CEO of High Tide, said it was a vote of confidence from the company’s fellow Alberta-based enterprise. Grover indicated that the proceeds will be used to fund retail acquisitions, store upgrades and further strategic acquisitions.

“The LPs have recognized our ability to produce products that are not related to the plant,” Kuzyk told INN. High Tide debuted publicly on the Canadian Securities Exchange on December 17.

According to Kuzyk, High Tide, which was launched originally in 2009, secured revenues of C$10 million in 2018 and its expected run-rate revenue will be close to C$25 million.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: High Tide is a client of the Investing News Network. This article is not paid-for content.

The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.

Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.

Keep reading... Show less

The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement

Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination

Keep reading... Show less

Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising

Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.

In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.

Keep reading... Show less

Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.

Keep reading... Show less